Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · FORT WORTH, TX · NPI 1083649446
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 296 | 62 |
| Atorvastatin Calcium | Atorvastatin Calcium | 278 | 64 |
| Losartan Potassium | Losartan Potassium | 205 | 42 |
| Amlodipine Besylate | Amlodipine Besylate | 188 | 41 |
| Furosemide | Furosemide | 188 | 51 |
| Gabapentin | Gabapentin | 188 | 39 |
| Lisinopril | Lisinopril | 187 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 128 | 24 |
| Eliquis | Apixaban | 128 | 24 |
| Potassium Chloride | Potassium Chloride | 122 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 117 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 115 | 37 |
| Donepezil Hcl | Donepezil Hcl | 115 | 17 |
| Pantoprazole Sodium | Pantoprazole Sodium | 115 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 112 | 23 |
| Trazodone Hcl | Trazodone Hcl | 109 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 106 | 25 |
| Sertraline Hcl | Sertraline Hcl | 100 | 16 |
| Famotidine | Famotidine | 95 | 21 |
| Omeprazole | Omeprazole | 94 | 21 |
| Carvedilol | Carvedilol | 91 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 91 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 91 | 22 |
| Montelukast Sodium | Montelukast Sodium | 91 | 23 |
| Allopurinol | Allopurinol | 88 | 12 |
| Memantine Hcl | Memantine Hcl | 87 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 19 |
| Jardiance | Empagliflozin | 84 | 18 |
| Ozempic | Semaglutide | 84 | 12 |
| Buspirone Hcl | Buspirone Hcl | 83 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 15 |
| Tramadol Hcl | Tramadol Hcl | 78 | 22 |
| Torsemide | Torsemide | 75 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 71 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 14 |
| Mirtazapine | Mirtazapine | 62 | suppressed |
| Spironolactone | Spironolactone | 61 | 11 |
| Finasteride | Finasteride | 56 | 11 |
| Alprazolam | Alprazolam | 53 | 11 |
| Prednisone | Prednisone | 53 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 52 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 51 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 50 | 14 |
| Aripiprazole | Aripiprazole | 49 | suppressed |
| Myrbetriq | Mirabegron | 48 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | suppressed |
| Metformin Hcl | Metformin Hcl | 46 | 14 |
| Celecoxib | Celecoxib | 44 | 14 |
| Linzess | Linaclotide | 43 | suppressed |
| Digoxin | Digoxin | 42 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Pregabalin | Pregabalin | 37 | suppressed |
| Nifedipine Er | Nifedipine | 36 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 36 | suppressed |
| Simvastatin | Simvastatin | 35 | suppressed |
| Levetiracetam | Levetiracetam | 34 | 12 |
| Meloxicam | Meloxicam | 34 | suppressed |
| Ibuprofen | Ibuprofen | 32 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 32 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 32 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Nystatin | Nystatin | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 28 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 26 | 12 |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Rybelsus | Semaglutide | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Testosterone | Testosterone | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 11 |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 16 | suppressed |
| Klor-Con 10 | Potassium Chloride | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error